Labeling studies of some carbonylation reactions of styrene with cationic palladium complexes

The dicarbonylation reaction of E-β-deuteriostyrene to syndiotactic poly(1-oxo-2-phenyltrimethylene) as well as to dimethyl-2-phenylbutanedioate and dimethyl-2,5-diphenyl-4-oxoheptanedioate using Pd(CF₃COO)₂/2,2′-bipyridine as the catalyst precursor in the presence of 1,4-benzoquinone in methanol takes place stereospecifically in a syn-fashion with complete retention of the label. The same result was found for the dicarbonylation to dimethyl 2-phenylbutanedioate catalyzed by [Pd(CF₃COO)₂(Diop)]. In the absence of the oxidant the latter catalytic system produces methyl 2- and 3-phenylpropionates for which some scrambling of deuterium is observed when using either -deuteriostyrene or CH₃OD as the labeled substrate. [Pd(CH₃CN)₄][BF₄]₂ modified with different ligands catalyses the formation of E-1,5-diphenylpent-1-en-3-one or of E-1,4-diphenylpent-1-en-3-one in tetrahydrofuran as the solvent. The label distribution using E-β-deuteriostyrene as the substrate (or styrene in the presence of dideuterium) suggests that in the synthesis of ketones catalyzed by [Pd(p-CH₃C₆H₄SO₃)₂(Dppp)]·2H₂O the regioselectivity of the first inserted olefin unit does not determine the ketone regioisomer; rather which regioisomeric product preferentially forms depends on the rate of carbon monoxide insertion in either the branched or linear metal-hydrocarbyl intermediate. β-Hydrogen elimination is very rapid both after the first and the second olefin insertion.     

Metabolic responses of homing pigeons to flight and subsequent recovery

This study examines metabolic changes occurring during short to endurance flights and during subsequent recovery in free-flying pigeons, in particular the change towards lipid utilization with increasing flight duration, lipid supply to the flight muscles, protein utilization and the time needed to metabolically recover. Eight plasma metabolite concentrations were measured in homing pigeons released from sites 20–200 km from the loft (0.3–4.8 h flight duration) just after landing and after keeping birds fasting at rest for 30 and 60 min, respectively, after their return. Birds kept in the loft fasting at rest were used as controls. Plasma free fatty acid and glycerol concentrations increased rapidly with flight duration and leveled off after about 1.5 h. This indicates a marked change towards a high and stable lipid utilization from adipose tissues within 1–2 h of flight. Plasma triglyceride levels and very-low-density lipoproteins were decreased after short flights, but subsequently regained or surpassed fasting levels at rest. This indicates that re-esterification of free fatty acids and delivery as very-low-density lipoproteins to the flight muscles to circumvent constraints of fatty acid supply, as described previously for small passerines, is not as significant in the pigeon which has a much lower mass-specific energy rate. An initial increase in plasma glucose levels and a transient decrease to fasting levels at rest was observed and may reflect the initial use and subsequent exhaustion of glycogen stores. Contrary to other birds and mammals, -hydroxy-butyrate levels increased markedly with flight duration. This may suggest a more important sparing of carbohydrates and protein as gluconeogenic precursors in the pigeon than in other species. Plasma uric acid levels increased linearly up to about 4 h flight duration. This indicates an accelerated protein breakdown during flight which may primarily serve to deliver amino acids as glucogenic precursors and citrate cycle intermediates. With increasing flight duration, the energy sources change from an initial phase based primarily on carbohydrates to a lipid-based endurance phase. It is discussed whether this metabolic change depends on the level of power output or the performed work (energy spent) since the start of flight. During the first hour of recovery, most metabolites reached or approached fasting levels at rest, indicating a marked reduction in lipolysis and protein breakdown. -hydroxy-butyrate levels remained at flight levels and glucose levels increased slightly, indicating a restoration of glycogen stores.Abbreviations VLDL very-low-density lipoproteins - FFA free fatty acids     

The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme

The effects of cannabinoids on ketogenesis in primary cultures of rat astrocytes were studied. Delta9-Tetrahydrocannabinol (THC), the major active component of marijuana, produced a malonyl-CoA-independent stimulation of carnitine palmitoyltransferase I (CPT-I) and ketogenesis from [14C]palmitate. The THC-induced stimulation of ketogenesis was mimicked by the synthetic cannabinoid HU-210 and was prevented by pertussis toxin and the CB1 cannabinoid receptor antagonist SR141716. Experiments performed with different cellular modulators indicated that the THC-induced stimulation of ketogenesis was independent of cyclic AMP, Ca2+, protein kinase C, and mitogen-activated protein kinase (MAPK). The possible involvement of ceramide in the activation of ketogenesis by cannabinoids was subsequently studied. THC produced a CB1 receptor-dependent stimulation of sphingomyelin breakdown that was concomitant to an elevation of intracellular ceramide levels. Addition of exogenous sphingomyelinase to the astrocyte culture medium led to a MAPK-independent activation of ketogenesis that was quantitatively similar and not additive to that exerted by THC. Furthermore, ceramide activated CPT-I in astrocyte mitochondria. Results thus indicate that cannabinoids stimulate ketogenesis in astrocytes by a mechanism that may rely on CB1 receptor activation, sphingomyelin hydrolysis, and ceramide-mediated activation of CPT-I.     

Reactions of ketones with coordinated nitriles on β-diketonato ruthenium complexes leading to formation of compounds with new carbon-carbon bonds

The reactions of [Ru(acac)₂(CH₃CN)₂] with four ketones (acetone, ethyl methyl ketone, acetylacetone and monochloroacetone), and the reactions of [Ru(acac)₂(C₆H₅CN)₂] with two ketones (acetone and ethyl methyl ketone) yielded six novel compounds of β-ketiminato ruthenium complexes: [Ru(acac)₂(mhmk)], [Ru(acac)₂(ehmk)], [Ru(acac)₂(mAmk)], [Ru(acac)₂(mClmk)], Ru(acac)₂(mhbk)], and [Ru(acac)₂(ehbk)] (mhmk = 4-iminopentane-2-one mono anion, ehmk = 5-iminohexane-3-one mono anion, mAmk = 3-(1-iminoethyl)-2,4-pentanedione mono anion, mClmk = 3-chloro-4-imino-pentane-2-one mono anion, mhbk = 1-phenyl-1-iminobutane-3-one mono anion, ehbk = 1-phenyl-1-iminopentane-3-one mono anion). All the new complexes have been characterized by elemental analyses, ¹H NMR, MS and electronic spectral data. Crystal and molecular structures for the six β-ketimine complexes have been solved by single crystal X-ray diffraction studies. A mechanism involving the attack of ketones on the coordinated nitrile has been proposed. The electrochemical redox behavior of the β-ketimine complexes has been elucidated.     

Quinoline transfer hydrogenation by a rhodium bipyridine catalyst

The catalytic activity of the rhodium complex cis-[Rh(bipy)₂Cl₂]Cl · 2H₂O in the transfer hydrogenation of different unsaturated substrates is reported. This complex, if pre-activated, is very active in the transfer hydrogenation of ketones (i.e., cyclohexanone is reduced with a 38.1% conversion at 283 K and 100% at 313 K) while in the case of hex-1-ene, a 36.8% conversion was reached at 293 K. A cyclic olefin (cyclohexene) was also reduced with a lower, but still significant, conversion.It is interesting to note the catalytic activity of this complex in the transfer hydrogenation of a CN double bond belonging to imides or nitrogen-containing heterocycles. For instance, N-benzylidenaniline was hydrogenated to N-benzylaniline at 303 K with a conversion of 27.3%. Increasing the temperature to 353 K, the conversion rised to 91.8%. A nitrogen containing heterocycle, quinoline, was also reduced by transfer hydrogenation at 353 K with a 11.7% conversion giving 1,2,3,4-tetrahydroquinoline (selectivity of 96.6%). The conversion rised up to 54.2% with a still high selectivity (84.5%) when the temperature was 383 K. Almost the same activity was shown in the reduction of pyridine to pyperidine (conversion, 51.1% at 383 K), while 2-methylpyridine was hydrogenated with a 24.7% conversion.     

Changes in Extracellular and Rat Brain Tissue Concentrations of D-β-Hydroxybutyrate After 1, 3-Butanediol Treatment

Abstract: 1, 3-Butanediol (BD) treatment was previously shown to produce a dose-related increase of the plasma levels of D-β-hydroxybutyrate (BHB) and to protect brain tissue against hypoxia and ischemia. The purpose of this study was to test whether BD-induced hyperketonemia was associated with changes in brain extracellular and tissue concentrations of BHB. Changes in extracellular levels of BHB were continuously monitored in anesthetized rats before and after intraperitoneal injection of BD (25 mmol/kg), using intracerebral microdialysis coupled to online analysis of BHB in the dialysate. Cortical tissue concentrations of BHB were determined in control and BD- treated rats (25 and 50 mmol/kg, i.p.) after freezing of the brain in situ. Butanediol produced a rapid increase in dialysate levels of BHB, with a linear relationship between dialysate and plasma BHB concentrations ( r = 0.81, p < 0.001). In contrast, and although brain tissue levels of BHB were markedly increased after BD treatment, they were not related to the plasma concentration of BHB. Our results suggest that BHB produced from BD did not accumulate in brain and that BD protects against hypoxia or ischemia by increasing brain BHB availability.     

Acetoacetate enhancement of glucose mediated DNA glycation

Acetoacetate (AA) is a ketone body, which generates reactive oxygen species (ROS). ROS production is impacted by the formation of covalent bonds between amino groups of biomacromolecules and reducing sugars (glycation). Glycation can damage DNA by causing strand breaks, mutations, and changes in gene expression. DNA damage could contribute to the pathogenesis of various diseases, including neurological disorders, complications of diabetes, and aging. Here we studied the enhancement of glucose-mediated DNA glycation by AA for the first time. The effect of AA on the structural changes, Amadori and advanced glycation end products (AGEs) formation of DNA incubated with glucose for 4 weeks were investigated using various techniques. These included UV–Vis, circular dichroism (CD) and fluorescence spectroscopy, and agarose gel electrophoresis. The results of UV–Vis and fluorescence spectroscopy confirmed that AA increased the DNA-AGE formation. The NBT test showed that AA also increased Amadori product formation of glycated DNA. Based on the CD and agarose gel electrophoresis results, the structural changes of glycated DNA was increased in the presence of AA. The chemiluminescence results indicated that AA increased ROS formation. Thus AA has an activator role in DNA glycation, which could enhance the adverse effects of glycation under high glucose conditions.     

Acetoacetate and Glucose as Lipid Precursors and Energy Substrates in Primary Cultures of Astrocytes and Neurons from Mouse Cerebral Cortex

Primary cultures of astrocytes and neurons derived from neonatal and embryonic mouse cerebral cortex, respectively, were incubated with [3-14C]acetoacetate or [2-14C]glucose. The utilization of glucose and acetoacetate, the production of lactate, D-3-hydroxybutyrate, and 14CO2, and the incorporation of 14C and of 3H from 3H2O into lipids and lipid fractions were measured. Both cell types used acetoacetate as an energy substrate and as a lipid precursor; lactate was the major product of glucose metabolism. About 60% of the acetoacetate that was utilized by neurons was oxidized to CO2, whereas this was only approximately 20% in the case of cultured astrocytes. This indicates that the rate at which 14C-labeled Krebs cycle intermediates exchange with pools of unlabeled intermediates is much higher in astrocytes than in neurons. Acetoacetate is a better precursor for the synthesis of fatty acids and cholesterol than glucose, presumably because it can be used directly in the cytosol for these processes; preferential incorporation into cholesterol was not observed in these in vitro systems. We conclude that ketone bodies can be metabolized both by the glial cells and by the neuronal cells of developing mouse brain.     

The combined effect of Raspberry Ketone with Resveratrol against oxidative stress and steatohepatitis in rats: Pharmacokinetic and pharmacodynamic studies

Raspberry Ketone (RK) and Resveratrol (RSV) are natural phenolic antioxidants and anti-inflammatory agents. However, its combined pharmacokinetic and pharmacodynamics potentials are not reported. The study aims to assess the combined effect of RK with RSV to protect rats from carbon-tetrachloride (CCl4) induced oxidative stress and NASH. The toxicant CCl4 was employed at a concentration of 1 mL/kg as a 1:1 (v/v) mixture with olive oil twice weekly for 6 weeks to induce liver toxicity. Animal treatment was followed for 2 weeks. Silymarin was used as a standard control drug to compare the hepatoprotective effect of RK and RSV. Hepatic histology, oxidative stress, MMP, reduced glutathione (GSH), plasma levels of SGOT, SGPT, and lipid profile (total cholesterol and triglycerides) were measured. Anti-inflammation genes (IL-10), and fibrotic genes (TGF-β) were also examined in liver tissue. Oral administration of combined RK with RSV (50 + 50 mg/kg for 2 weeks) showed significantly more hepatoprotection by significantly decreasing elevated plasma markers and lipid profile than alone RK and RSV (100 mg/kg daily for 2 weeks). It also significantly alleviated the hepatic lipid peroxidation, restoring the activities of GSH levels in the liver. RT-PCR and Immunoblotting studies confirmed that significantly upregulation of anti-inflammation genes and protein expression (MMP-9) ameliorated the disease. Pharmacokinetic studies confirmed more synergistic stability in simulated gastric-intestinal fluids (FaSSGF, FaSSIF) and rat liver microsomes (CYP-450, NADPH oxidation & glucuronidation. Moreover, coadministration of drugs augmented the relative bioavailability, V_d/F (L/Kg), and MRT_0-∞(h), which leads to more efficacy. This pharmacokinetic and pharmacodynamic reveals a new adjuvant therapy for the treatment of steatohepatitis.     

Fats for thoughts: An update on brain fatty acid metabolism

Brain fatty acid (FA) metabolism deserves a close attention not only for its energetic aspects but also because FAs and their metabolites/derivatives are able to influence many neural functions, contributing to brain pathologies or representing potential targets for pharmacological and/or nutritional interventions.Glucose is the preferred energy substrate for the brain, whereas the role of FAs is more marginal. In conditions of decreased glucose supply, ketone bodies, mainly formed by FA oxidation, are the alternative main energy source. Ketogenic diets or medium-chain fatty acid supplementations were shown to produce therapeutic effects in several brain pathologies.Moreover, the positive effects exerted on brain functions by short-chain FAs and the consideration that they can be produced by intestinal flora metabolism contributed to the better understanding of the link between “gut-health” and “brain-health”.Finally, attention was paid also to the regulatory role of essential polyunsaturated FAs and their derivatives on brain homeostasis.